The Clorox Company (NYSE:CLX) Holdings Raised by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC boosted its stake in The Clorox Company (NYSE:CLXFree Report) by 11.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 213,697 shares of the company’s stock after buying an additional 21,778 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Clorox were worth $34,707,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Exchange Capital Management Inc. lifted its position in Clorox by 16.6% in the 4th quarter. Exchange Capital Management Inc. now owns 6,157 shares of the company’s stock worth $1,000,000 after buying an additional 878 shares in the last quarter. BankPlus Trust Department purchased a new stake in Clorox in the 4th quarter worth approximately $40,000. IFP Advisors Inc lifted its position in Clorox by 16.9% in the 4th quarter. IFP Advisors Inc now owns 4,516 shares of the company’s stock worth $733,000 after buying an additional 653 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new position in shares of Clorox during the 4th quarter valued at $285,000. Finally, MONECO Advisors LLC raised its holdings in shares of Clorox by 22.6% during the 4th quarter. MONECO Advisors LLC now owns 1,955 shares of the company’s stock valued at $318,000 after purchasing an additional 361 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

NYSE CLX opened at $157.00 on Wednesday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The firm has a market capitalization of $19.34 billion, a price-to-earnings ratio of 42.90, a P/E/G ratio of 2.62 and a beta of 0.42. The company’s fifty day moving average is $157.40 and its two-hundred day moving average is $160.13. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the business posted $2.16 EPS. Equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.11%. Clorox’s dividend payout ratio is 133.33%.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on CLX shares. JPMorgan Chase & Co. raised their price target on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Wells Fargo & Company raised their price target on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. DA Davidson cut their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Royal Bank of Canada restated a “sector perform” rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Finally, StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, Clorox presently has a consensus rating of “Hold” and a consensus price target of $158.21.

Read Our Latest Research Report on Clorox

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.